DUBLIN–(BUSINESS WIRE)–The “Innovations and Growth Opportunities in Microfluidics, Point of Care Diagnostics and Digital Health” report has been added to ResearchAndMarkets.com’s offering.
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes advanced diagnostic technologies such as microfluidic-based point-of-care diagnostics, diagnostic biochips, AI-enabled breast cancer, and stroke diagnosis, genomic test for melanoma, or sticker based pediatric cystic fibrosis diagnosis.
Some of the advanced medical device technologies such as nano-pulse stimulation technology, retinal prosthesis system, dry powder nebulizer, and nanotechnology-based blood purification system have been covered in this issue. Digital health solutions such as digital therapeutics for chronic condition management, digital colposcope, and AI in imaging are also included in this issue. These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact. The growth opportunities for all these advanced medical device technologies are also covered in this issue.
The Advanced MedTech TOE analyzes and reports new and emerging technologies; advances in R&D, product development, and regulatory matters specifically related to the areas of wearables, implantables, diagnostics, surgical tools and instrumentation, image-guided surgery, drug delivery, patient monitoring, digital health, and medical imaging. Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.
Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.
Key Topics Covered:
1. Innovations in Medical Devices and Imaging
- Thermoplastic Elastomer for Biomicrofluidic Devices
- Value Proposition of Eden Tech
- Eden Tech – Investor Dashboard
- Microfluidics-based Point-of-care (POC) Blood Coagulation Diagnostics
- Value Proposition of Enzyre
- Enzyre – Investor Dashboard
- Epigenetic Clock Technology for Health and Aging Measurement
- Value Proposition of FOXO Technologies
- FOXO Technologies – Investor Dashboard
- Non-invasive Genomic Analysis Test for Melanoma
- Value Proposition of Akonni Biosystems
- Akonni Biosystems – Investor Dashboard
- Microfluidic Protein Microarray-based Point-of-care Diagnostics
- Sanwa BioTech’s Value Proposition
- Sanwa BioTech – Investor Dashboard
- High-fidelity Implantable Neural Probes
- Diagnostic Biochips’ Value Proposition
- Diagnostic Biochips – Investor Dashboard
- Indoor Positioning Platform for Providing Seamless Navigation for Patients
- Pointr Limited’s Value Proposition
- Pointr Limited – Investor Dashboard
- Digital Therapeutics Platform for Managing Chronic Conditions
- Sidekick Health’s Value Proposition
- Sidekick Health – Investor Dashboard
- Wristband for Menopausal Hot Flashes Management
- Embr Labs Inc.’s Value Proposition
- Embr Labs Inc. – Investor Dashboard
- Nano-pulse Stimulation Technology for Treating Benign Lesions
- Pulse Biosciences Inc.’s Value Proposition
- Pulse Biosciences Inc. – Investor Dashboard
- Digital Therapeutic Platform Treating Chronic Fecal Incontinence in Women
- Renovia – Value Proposition
- Renovia – Investor Dashboard
- Retinal Prostheses System for Providing Artificial Vision to Patients
- Pixium Vision – Value Proposition
- Pixium Vision – Investor Dashboard
- Digital Colposcope for Point-of-Care Cervical Cancer Detection
- Biop Medical’s Value Proposition
- Biop Medical – Investor Dashboard
- Artificial Intelligence (AI)-powered Software for Early Diagnosis of Stroke
- Cerebra AI’s Value Proposition
- Cerebra AI – Investor Dashboard
- Dry Powder Nebulizer for Lower Respiratory Tract Infection Treatment
- NHT’s Value Proposition
- NHT – Investor Dashboard
- Nanotechnology-based Blood Purification System for Toxin Removal
- hemotune’s Value Proposition
- hemotune – Investor Dashboard
- Digital Pain Drawing Software to Quantify and Analyze Pain Distribution in Patients
- University of Thessaly – Value Proposition
- AI System for Improving Accuracy of Breast Cancer Diagnosis in Ultrasound Images
- New York University Abu Dhabi – Value Proposition
2. Key Contacts
3. Appendix
- Criteria for Rating of Innovations – Explanation
- Legal Disclaimer
Companies Mentioned
- Akonni Biosystems
- Biop Medical
- Cerebra AI
- Diagnostic Biochips
- Eden Tech
- Embr Labs Inc
- Enzyre
- FOXO Technologies
- hemotune
- New York University Abu Dhabi
- NHT
- Pixium Vision
- Pointr Limited
- Pulse Biosciences Inc
- Renovia
- Sanwa BioTech
- Sidekick Health
- University of Thessaly
For more information about this report visit https://www.researchandmarkets.com/r/qh8hfe
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
